These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25861812)

  • 21. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government.
    Anderson KP
    J Interv Card Electrophysiol; 2005 Nov; 14(2):71-8. PubMed ID: 16374553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sudden cardiac death: epidemiology, mechanisms, and therapy.
    Turakhia M; Tseng ZH
    Curr Probl Cardiol; 2007 Sep; 32(9):501-46. PubMed ID: 17723906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of the cause of death of ICD patients during long-term follow-up].
    Fiek M; Zieg B; Matis T; Hahnefeld A; Reithmann C; Steinbeck G
    Herzschrittmacherther Elektrophysiol; 2006 Mar; 17(1):6-12. PubMed ID: 16547654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantable cardioverter defibrillators in diabetics: efficacy and safety in patients at risk of sudden cardiac death.
    Shahreyar M; Mupiddi V; Choudhuri I; Sra J; Tajik AJ; Jahangir A
    Expert Rev Cardiovasc Ther; 2015; 13(8):897-906. PubMed ID: 26098816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The assessment of factors influencing occurrence of adequate interventions of cardiac resynchronization therapy with cardioverter-defibrillator implanted in primary prevention of sudden cardiac death in dilative cardiomyopathy and percentage of biventricular pacing].
    Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J; Matusik P
    Przegl Lek; 2017; 74(4):157-62. PubMed ID: 29696953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
    Hilleman DE; Bauman AL
    Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac electronic implantable devices in the treatment of heart failure.
    Tan TC; Sindone AP; Denniss AR
    Heart Lung Circ; 2012 Jun; 21(6-7):338-51. PubMed ID: 22682103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 12-Lead electrocardiogram as a predictor of sudden cardiac death: from epidemiology to clinical practice.
    Eranti A; Aro AL; Kenttä T; Holkeri A; Tikkanen JT; Junttila MJ; Huikuri HV
    Scand Cardiovasc J; 2016; 50(5-6):253-259. PubMed ID: 27454252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification and epidemiology of sudden death.
    Sundaram S; Goldberger JJ
    Curr Cardiol Rep; 2004 Sep; 6(5):333-8. PubMed ID: 15306089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk stratification for sudden cardiac death in North America - current perspectives.
    Buxton AE; Waks JW; Shen C; Chen PS
    J Electrocardiol; 2016; 49(6):817-823. PubMed ID: 27524476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary prevention of sudden cardiac death in heart failure: will the solution be shocking?
    Uretsky BF; Sheahan RG
    J Am Coll Cardiol; 1997 Dec; 30(7):1589-97. PubMed ID: 9385881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    Bilchick KC; Wang Y; Cheng A; Curtis JP; Dharmarajan K; Stukenborg GJ; Shadman R; Anand I; Lund LH; Dahlström U; Sartipy U; Maggioni A; Swedberg K; O'Conner C; Levy WC
    J Am Coll Cardiol; 2017 May; 69(21):2606-2618. PubMed ID: 28545633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States.
    Charytan DM; Patrick AR; Liu J; Setoguchi S; Herzog CA; Brookhart MA; Winkelmayer WC
    Am J Kidney Dis; 2011 Sep; 58(3):409-17. PubMed ID: 21664735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation.
    Sweeney MO; Ruskin JN; Garan H; McGovern BA; Guy ML; Torchiana DF; Vlahakes GJ; Newell JB; Semigran MJ; Dec GW
    Circulation; 1995 Dec; 92(11):3273-81. PubMed ID: 7586314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stratification of the risk of sudden death in nonischemic heart failure.
    Pimentel M; Zimerman LI; Rohde LE
    Arq Bras Cardiol; 2014 Oct; 103(4):348-57. PubMed ID: 25352509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary prevention of sudden cardiac death: apart from the defibrillator, what is important in patients with myocardial infarction or heart failure?
    Kallergis EM; Vardas PE
    Hellenic J Cardiol; 2007; 48(2):89-93. PubMed ID: 17489346
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.